Author: Scott Welch
Independent hospitals could need to make drastic decisions such as reducing service lines or workforces to survive the cash crisis caused by the COVID-19 pandemic, a new analysis finds.
Nevada added 239 new COVID-19 cases and 23 deaths over the preceding day, as the state’s infection or positivity rate registered its first decline in nearly a month, according to state data posted Wednesday.
President Donald Trump said on Tuesday he planned to meet with pharmaceutical companies this week regarding his so-called most- favored-nation executive order aimed at lowering drug prices paid by the U.S. federal government.
The Centers for Disease Control and Prevention has asked states to prepare to distribute a potential coronavirus vaccine as soon as late October, according to a series of planning documents sent to public health officials last week.
California Gov. Gavin Newsom (D) launched a new plan to more slowly reopen his state’s economy after an alarming spike in coronavirus cases across the Golden State over the summer.
California lawmakers on Monday wrapped up a legislative session largely defined by the pandemic as they approved new COVID-19 sick leave for food workers, added sweeping labor protections for laid-off hotel staff and made it easier for essential employees to file for workers’ compensation.
Treasury Secretary Steven Mnuchin said Monday that Senate Majority Leader Mitch McConnell (R-Ky.) will “hopefully” unveil a new coronavirus relief bill next week.
A Delaware court ruled Monday that neither Anthem nor Cigna Corp. may recover any damages after they failed to complete their proposed $54 billion merger, which would have created the nation's largest health insurer.
The White House announced a deal Thursday with Abbott Laboratories to produce 150 million rapid coronavirus tests that will allow users to obtain results in 15 minutes from a small card.
California is poised to become the first state to develop its own line of generic drugs, targeting soaring drug prices and stepping into a fiercely competitive drug market dominated by deep-pocketed pharmaceutical companies.